Gene therapy firm AavantiBio procures $107m Series A
AavantiBio, a gene therapy company, has raised $107 million in Series A funding.
AavantiBio, a gene therapy company, has raised $107 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination